TABLE 1.
Baseline characteristics and clinical response for enrolled patients
| Patient characteristics (N = 21) | N (% or range) |
|---|---|
| Patient factors | |
| Age (mean), years | 47 (28–61) |
| Gender | |
| Female | 21 (100) |
| Male | 0 (0) |
| Subtype | |
| Triple negative | 21 (100) |
| Non‐triple negative | 0 (0) |
| Tumor factors (before NAC) | |
| MR tumor size(cm) | |
| cT1 | 2 (9.5) |
| cT2 | 12 (57.1) |
| cT3 | 6 (28.6) |
| NA | 1(4.8) |
| RCB system | |
| pCR (RCB0) | 6 (28.6) |
| non‐pCR (RCBI‐III) | 15 (71.4) |
| MP system | |
| MP5 | 8 (38.1) |
| MP1‐4 | 13 (61.9) |
Abbreviations: cT, clinical T stage; MP system, Miller‐Payne system; RCB system, Residual Cancer Burden system.